291 related articles for article (PubMed ID: 12101116)
21. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW
JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501
[TBL] [Abstract][Full Text] [Related]
22. Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot study.
Akasu T; Yokoyama T; Sugihara K; Fujita S; Moriya Y; Kakizoe T
Hepatogastroenterology; 2002; 49(47):1259-61. PubMed ID: 12239919
[TBL] [Abstract][Full Text] [Related]
23. Luminal and humoral influences on human rectal epithelial cytokinetics.
Thomas MG
Ann R Coll Surg Engl; 1995 Mar; 77(2):85-9. PubMed ID: 7793821
[TBL] [Abstract][Full Text] [Related]
24. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
25. Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis.
Friederich P; van Heumen BW; Nagtegaal ID; Berkhout M; van Krieken JH; Peters WH; Nagengast FM
Virchows Arch; 2007 Sep; 451(3):659-67. PubMed ID: 17611772
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM
Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996
[TBL] [Abstract][Full Text] [Related]
27. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients].
Li J; Lv YM; Jin Z; Cui RL
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):371-3. PubMed ID: 16086054
[TBL] [Abstract][Full Text] [Related]
28. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
Seike K; Koda K; Oda K; Kosugi C; Shimizu K; Nishimura M; Shioiri M; Takano S; Ishikura H; Miyazaki M
Am J Gastroenterol; 2006 Jun; 101(6):1362-9. PubMed ID: 16771962
[TBL] [Abstract][Full Text] [Related]
29. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis.
Wang LS; Burke CA; Hasson H; Kuo CT; Molmenti CL; Seguin C; Liu P; Huang TH; Frankel WL; Stoner GD
Cancer Prev Res (Phila); 2014 Jul; 7(7):666-74. PubMed ID: 24764585
[TBL] [Abstract][Full Text] [Related]
30. Cell reconstruction of the rectal mucosa in patients with familial adenomatous polyposis: endoscopy, morphology, immunohistochemistry.
Kogan EA; Vyshegorodtsev DV; Faizullina NM; Demura TA; Kuz'minov AM; Shelygin YA; Sukhikh GT
Bull Exp Biol Med; 2014 Sep; 157(5):683-8. PubMed ID: 25257440
[TBL] [Abstract][Full Text] [Related]
31. Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid.
Nobuoka A; Takayama T; Miyanishi K; Sato T; Takanashi K; Hayashi T; Kukitsu T; Sato Y; Takahashi M; Okamoto T; Matsunaga T; Kato J; Oda M; Azuma T; Niitsu Y
Gastroenterology; 2004 Aug; 127(2):428-43. PubMed ID: 15300575
[TBL] [Abstract][Full Text] [Related]
32. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
[TBL] [Abstract][Full Text] [Related]
33. Advanced precancerous lesions (APL) in the colonic mucosa.
Naini BV; Odze RD
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):235-56. PubMed ID: 23809243
[TBL] [Abstract][Full Text] [Related]
34. The ileo neo rectal anastomosis (INRA) in patients with familial adenomatous polyposis: clinical results at two years.
Strijbos SA; Hueting WE; Schipper ME; Oostvogel HJ; van Vroonhoven TJ; Gooszen HG; van Laarhoven CJ
Colorectal Dis; 2005 Jul; 7(4):354-9. PubMed ID: 15932558
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
[TBL] [Abstract][Full Text] [Related]
36. Familial polyposis: a case study.
Ben Meir Z; Garber A; Rassin M; Silner D
Gastroenterol Nurs; 2008; 31(4):275-8. PubMed ID: 18708831
[TBL] [Abstract][Full Text] [Related]
37. Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
Friederich P; Verschuur J; van Heumen BW; Roelofs HM; Berkhout M; Nagtegaal ID; van Oijen MG; van Krieken JH; Peters WH; Nagengast FM
Int J Colorectal Dis; 2011 May; 26(5):575-82. PubMed ID: 21243500
[TBL] [Abstract][Full Text] [Related]
38. [Neoplastic polyp of the large intestine and polyposis (tubular adenoma and tubulovillous adenoma)].
Saito Y; Sawada T; Muto T
Ryoikibetsu Shokogun Shirizu; 1994; (6):300-2. PubMed ID: 7736051
[No Abstract] [Full Text] [Related]
39. A case of cancerous familial adenomatous polyposis in urinary bladder due to migration of colonic mucosa through rectovesical fistula.
Matsuo H; Kato T; Hirai T; Kodera Y; Kito T; Nakamura H
Am J Gastroenterol; 2000 May; 95(5):1352-4. PubMed ID: 10811353
[TBL] [Abstract][Full Text] [Related]
40. [Autoradiography of DNA synthesis in colonic mucosa of patients with familial adenomatosis coli].
Steenbeck L; Jacobasch KH; Irro F
Acta Histochem Suppl; 1990; 39():249-57. PubMed ID: 1964234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
